Gladstone’s Melanie Ott and Alex Marson Elected to the National Academy of Medicine
Physician-scientists and directors at Gladstone Institutes, Ott and Marson are honored for their pioneering achievements in science and medicine.
The Technologies We’re Developing
At Gladstone, we not only use the latest technology—we build it.
From AI models to novel vaccine approaches, our scientists are creating bleeding-edge computational tools and molecular technologies to accelerate research across every disease area. Our researchers also continue to build on iPS cells and CRISPR, technologies pioneered by scientists who now call Gladstone home, pushing even further the boundaries of what’s possible in science.
Phage Therapy
Scientists at Gladstone are developing new ways to engineer and optimize phages to counter drug-resistant infections, which represent one of the world’s most urgent health threats.
iPS Cells
One of the most important advances in modern biomedical research, iPS cells help Gladstone researchers study disease, screen drugs, and develop potential cell therapies.
Artificial Intelligence
At Gladstone, our scientists are creating some of the world’s most advanced AI models in biomedical research—allowing both experiments in living cells and AI itself to advance faster.
CRISPR Genome Editing
Gladstone researchers are using CRISPR and advancing gene-editing approaches to better understand disease, develop new diagnostics, and design next-generation therapies.
Vaccine Innovation
At Gladstone, scientists are developing innovative vaccines that generate better immune responses to respond to future pandemics and some of medicine’s greatest unmet challenges.
Related News
Read
In Alzheimer’s Disease, the Brain’s Pacemaker Cells Lose Their Beat
Research in mice reveals how critical brain cells misfire in Alzheimer’s and identifies a targeted strategy to restore healthy brain rhythms.
Read
Gladstone Institutes Launches Redesigned Website, Bringing Cutting-Edge Biomedical Research Into Focus
Discover disease research, explore the latest scientific news, and connect with experts through Gladstone’s enriched digital platform.
Read
Newly Discovered Antiviral System in Bacteria Is ‘Strangest of Its Kind’
The complex Rube Goldberg-like molecular machinery could inspire novel technology to study and treat disease.
Read
Gladstone’s Seth Shipman Named Fellow of the California Academy of Sciences
Shipman is recognized for pioneering molecular technologies that record cellular activity, expand genome editing, and target antibiotic-resistant superbugs.
Get Involved
Join the Team
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsPartner With Us
Discoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreGive
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now